Novo Nordisk’s blockbuster drug Ozempic (NVO) is linked to yet another health benefit. This time it’s lowering the risk of ...

Alzheimer’s disease is a brain disorder that slowly destroys memory and thinking skills. The post Drug in Ozempic may also ...

A new study by researchers at Florida State University's Gut Biome Lab has revealed a potential link between an infection ...

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...

A new bombshell has been dropped in the scandal-plagued world of Alzheimer’s disease drug development. | Between the two ...

Authorities have confirmed that a mummified body was found on a toilet inside a California home while they were looking for a ...

Researchers have linked Novo Nordisk’s semaglutide to a 40% to 70% reduction in the risk of Alzheimer’s disease diagnosis in ...

The GLP-1 RA semaglutide was associated with a 40%-70% reduced risk for first-time diagnosis of AD in patients with type 2 diabetes, real-world data show.

A collaborative research group has uncovered a new mechanism in the growth of amyloid β (Aβ) fibrils, which are closely ...

Alzamend Neuro has determined the dosage of AL001, its lithium therapy for Alzheimer’s disease, that will be used in future ...

A retired cop in Michigan called dispatchers to report he gave his wife a “merciful ending” to her Alzheimer’s disease before ...

Research reveals advanced brain aging in older adults correlates with cognitive decline and Alzheimer's risk, highlighting ...